Perspective Therapeutics Inc (CATX)

R&D Expenses

$95.05M

TTM · Period ending: · USD

CATX logo

CATX R&D Expenses

Latest reported$95.05M
CATX TTM R&D Expenses ($0.00 → $95.05M)
High-resolution chart · PNG

CATX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Perspective Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.